Turning a painkiller into a cancer killer: Pain reliever redirected to trigger death pathways in cancer cells

Without knowing exactly why, scientists have long observed that people who regularly take non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin have lower incidences of certain types of cancer. Now, in a new study, researchers have figured out how one NSAID, called Sulindac, inhibits tumor growth.

Read the whole article on Science Daily

More from Science Daily